scispace - formally typeset
F

Frederick A. Anderson

Researcher at University of Massachusetts Medical School

Publications -  223
Citations -  25653

Frederick A. Anderson is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Acute coronary syndrome & Myocardial infarction. The author has an hindex of 69, co-authored 221 publications receiving 23644 citations. Previous affiliations of Frederick A. Anderson include University of Natal & George Washington University.

Papers
More filters
Journal ArticleDOI

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study

TL;DR: Extrapolation of the data from this population-based study suggests that there are approximately 170,000 new cases of clinically recognized venous thromboembolism in patients treated in short-stay hospitals in the United States each year, and 99,000 hospitalizations for recurrent disease.
Journal ArticleDOI

Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.

TL;DR: A large proportion of hospitalised patients are at risk for VTE, but there is a low rate of appropriate prophylaxis, which reinforces the rationale for the use of hospital-wide strategies to assess patients' VTE risk and to implement measures that ensure that at-risk patients receive appropriate proPHylaxis.
Journal ArticleDOI

Risk factors for venous thromboembolism

TL;DR: Individual risk factors, or combinations thereof, can have important implications for the type and duration of appropriate prophylaxis and should be carefully reviewed to assess the overall risk of VTE in each patient.
Journal ArticleDOI

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

TL;DR: This risk prediction tool uses readily identifiable variables to provide robust prediction of the cumulative six month risk of death or myocardial infarction and can guide patient triage and management across the spectrum of patients with acute coronary syndrome.